Jenburkt Pharmaceuticals Limited

Jenburkt Pharmaceuticals Limited company information, Employees & Contact Information

Our purpose at Jenburkt Pharmaceuticals Ltd is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. We believe in serving our patients – through them, we serve God, humanity and nation. Way back in the twentieth century, a visionary in the field of healthcare and philanthropic work – Shri Nandlal Mulji Bhuta laid the foundation for several companies. Today, with over 850+ committed team members across functions pan-India,we have 11 million+ prescriptions generated annually from 400,000+ pharmacies across the globe. Our organisation caters to large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. We enjoy an international presence, with our products exported to 13 countries globally including niche segments. In an ever-changing health landscape, our rapt attention to market trends, innovation, our keen focus on quality above all else, and our team’s restless perseverance to deliver ground-breaking new healthcare solutions set us apart.

Company Details

Employees
287
Founded
-
Address
Nirmala Apartments, 93,j. P. Road,andheri West,india
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Mumbai, Maharashtra
Looking for a particular Jenburkt Pharmaceuticals Limited employee's phone or email?

Jenburkt Pharmaceuticals Limited Questions

News

Can Jenburkt Pharmaceuticals Limited Deliver Consistent Free Cash Flows - Insider Selling & Step-by-Step Swing Trade Plans - Trung tâm Dự báo KTTV quốc gia

Can Jenburkt Pharmaceuticals Limited Deliver Consistent Free Cash Flows - Insider Selling & Step-by-Step Swing Trade Plans Trung tâm Dự báo KTTV quốc gia

Jenburkt Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Jenburkt Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead Markets Mojo

Bridging Medical Knowledge: Jenburkt Pharmaceuticals Ltd and NIMHANS Launch First-Ever Neuropathy Masterclass Series - Tribune India

Bridging Medical Knowledge: Jenburkt Pharmaceuticals Ltd and NIMHANS Launch First-Ever Neuropathy Masterclass Series Tribune India

Jenburkt Pharma Standalone June 2025 Net Sales at Rs 35.53 crore, up 9.19% Y-o-Y - Moneycontrol

Jenburkt Pharma Standalone June 2025 Net Sales at Rs 35.53 crore, up 9.19% Y-o-Y Moneycontrol

Jenburkt Pharmaceuticals Reports Flat Financial Performance Amid Rising Non-Operating Income in May 2025 - Markets Mojo

Jenburkt Pharmaceuticals Reports Flat Financial Performance Amid Rising Non-Operating Income in May 2025 Markets Mojo

Jenburkt Wellness launches D2C brand Zixa Strong - An innovative, fast-acting pain relief range - Times of India

Jenburkt Wellness launches D2C brand Zixa Strong - An innovative, fast-acting pain relief range Times of India

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet - Business Standard

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet Business Standard

We had to make Favivent cost-effective for everyone - theweek.in

We had to make Favivent cost-effective for everyone theweek.in

Jenburkt Pharmaceuticals Reports Mixed Financial Results for December Quarter 2024 - Markets Mojo

Jenburkt Pharmaceuticals Reports Mixed Financial Results for December Quarter 2024 Markets Mojo

Jenburkt Pharma launches FDC- Nervijen D3 - Medical Dialogues

Jenburkt Pharma launches FDC- Nervijen D3 Medical Dialogues

Jenburkt Pharma: Steady as a Rock - Moneylife

Jenburkt Pharma: Steady as a Rock Moneylife

Jenburkt Pharma to consider share buyback - Express Pharma

Jenburkt Pharma to consider share buyback Express Pharma

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High Stock Price Amidst Positive Performance - Markets Mojo

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High Stock Price Amidst Positive Performance Markets Mojo

Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 - Express Pharma

Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 Express Pharma

Jenburkt Pharmaceuticals Reaches All-Time High, Outperforms Sector and Sensex - Markets Mojo

Jenburkt Pharmaceuticals Reaches All-Time High, Outperforms Sector and Sensex Markets Mojo

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex - Markets Mojo

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex Markets Mojo

Jenburkt Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 - shareprice-target.com

Jenburkt Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 shareprice-target.com

Top Jenburkt Pharmaceuticals Limited Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant